Lazard Asset Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-6,334
Closed -$92K – 2460
2023
Q3
$92K Sell
6,334
-2,484
-28% -$38.7K ﹤0.01% 1666
2023
Q2
$156K Hold
8,818
– – ﹤0.01% 1421
2023
Q1
$156K Hold
8,818
– – ﹤0.01% 1377
2022
Q4
$172K Buy
8,818
+4,414
+100% +$89.5K ﹤0.01% 1331
2022
Q3
$84K Buy
4,404
+553
+14% +$11.2K ﹤0.01% 1552
2022
Q2
$68K Buy
3,851
+787
+26% +$18.5K ﹤0.01% 1674
2022
Q1
$88K Hold
3,064
– – ﹤0.01% 1451
2021
Q4
$84K Buy
+3,064
New +$86.7K ﹤0.01% 1511
2021
Q3
– Sell
-3,634
Closed -$102K – 2292
2021
Q2
$102K Buy
3,634
+771
+27% +$20.5K ﹤0.01% 1335
2021
Q1
$63K Hold
2,863
– – ﹤0.01% 1346
2020
Q4
$53K Hold
2,863
– – ﹤0.01% 1370
2020
Q3
$44K Hold
2,863
– – ﹤0.01% 1223
2020
Q2
$43K Sell
2,863
-286
-9% -$4.25K ﹤0.01% 1266
2020
Q1
$40K Buy
3,149
+2,350
+294% +$42.1K ﹤0.01% 1272
2019
Q4
$19K Hold
799
– – ﹤0.01% 1249
2019
Q3
$16K Buy
+799
New +$16.5K ﹤0.01% 1138

Other funds holding TBI

Lazard Asset Management's TBI Position: Q4 2023 in Review

Lazard Asset Management sold out of Trueblue (TBI) in Q4 2023, closing a stake of 6,334 shares — an estimated $92K sold.

Lazard Asset Management first reported a position in TBI in Q3 2019 and held it in 16 quarters. The position peaked at $172K in Q4 2022. 152 funds tracked by Wall St. Rank hold TBI as of Q4 2023.

  • Lazard Asset Management reported no remaining Trueblue position as of Q4 2023 after selling out during the quarter.
  • Lazard Asset Management sold 6,334 Trueblue shares in Q4 2023, an estimated $92K.
  • Lazard Asset Management first reported a position in Trueblue in Q3 2019 and held it in 16 quarters.
  • Lazard Asset Management's Trueblue position peaked at $172K in Q4 2022.
  • 152 funds tracked by Wall St. Rank held Trueblue as of Q4 2023.

Based on Lazard Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.